Cargando…
Comparison of add-on medications for persistent storage symptoms after α-blocker treatment in BPH patients – a network meta-analysis
BACKGROUND: Patients with benign prostatic hyperplasia (BPH) receive α-blockers as first-line therapy to treat lower urinary tract symptoms; however, some individuals still experience residual storage symptoms. Antimuscarinics, β3-agonists, and desmopressin are effective add-on medications. Neverthe...
Autores principales: | Su, Yi-Ting, Chen, Hsiao-Ling, Teoh, Jeremy Yuen-Chun, Chan, Vinson Wai-Shun, Wu, Wen-Jeng, Lee, Hsiang-Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546657/ https://www.ncbi.nlm.nih.gov/pubmed/37789333 http://dx.doi.org/10.1186/s12894-023-01327-1 |
Ejemplares similares
-
Effects of α-blocker ‘add on' treatment on blood pressure in symptomatic BPH with or without concomitant hypertension
por: Lee, S H, et al.
Publicado: (2010) -
A retrospective study of treatment persistence and adherence to α-blocker plus antimuscarinic combination therapies, in men with LUTS/BPH in the Netherlands
por: Drake, Marcus J., et al.
Publicado: (2017) -
The Role of Combination Therapy with α-Blockers and Hexanic Extract of Serenoa repens in the Treatment of LUTS/BPH
por: De Nunzio, Cosimo, et al.
Publicado: (2022) -
Immune Checkpoints Inhibitors and Chemotherapy as First-Line Treatment for Metastatic Urothelial Carcinoma: A Network Meta-Analysis of Randomized Phase III Clinical Trials
por: Chen, Hsiao-Ling, et al.
Publicado: (2021) -
Complications of cataract surgery in patients with BPH treated with alpha 1A-blockers
por: Jan Teper, Slawomir, et al.
Publicado: (2011)